Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Mutations01:39

Mutations

Overview
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic Apheresis Registry of the Spanish Society of Nephrology. Analysis of activity over the last five years.

Nefrologia·2026
Same author

Increase in photosynthetic carbon assimilation and gas exchange through foliar application of melatonin in green bean plants.

Photosynthetica·2026
Same author

One Week, One Boost, One Goal: Feasibility, Safety and Local Control in Breast Ductal Carcinoma In Situ With Ultra-hypofractionated Radiotherapy and Simultaneous Integrated Boost.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

A cross-sectional pilot study to define anal cancer risk factors in HIV-positive solid organ transplant recipients.

Infectious diseases (London, England)·2025
Same author

Positive Neutrino Masses with DESI DR2 via Matter Conversion to Dark Energy.

Physical review letters·2025
Same author

Desmoid tumor: Clinical analysis and literature review.

Revista de gastroenterologia de Mexico (English)·2025

Related Experiment Videos

Autoinflammatory gene mutations in Behçet's disease.

I Koné-Paut1, E Sanchez, A Le Quellec

  • 1Department of Pediatrics and Pediatric Rheumatology, Hôpital de Bicêtre, 78 rue du Général Leclerc, 94270 Le Kremlin Bicêtre, France. isabelle.kone-paut@bct.aphp.fr

Annals of the Rheumatic Diseases
|January 11, 2007
PubMed
Summary

This study investigated genetic mutations in Behçet

Related Experiment Videos

Area of Science:

  • Genetics
  • Immunology
  • Rheumatology

Background:

  • Behçet's disease (BD) shares clinical features with autoinflammatory disorders.
  • Previous studies suggested increased mutations in familial Mediterranean fever and TNF receptor-associated periodic syndrome genes in BD patients.

Purpose of the Study:

  • To investigate the association between Behçet's disease and mutations in mevalonate kinase (MVK), cold-induced autoinflammatory syndrome 1 (CIAS1), and PSTPIP1 genes.
  • To determine if these genes are significantly more common in BD patients compared to healthy controls.

Main Methods:

  • DNA samples from 97 BD patients and 51 healthy controls were analyzed.
  • Screening for known mutations in MVK, CIAS1, and PSTPIP1 genes using restriction fragment length polymorphism analysis and sequencing.
  • Analysis included specific mutations responsible for mevalonate kinase deficiency (MKD), cryopyrin-associated periodic syndromes (CAPS), and PAPA syndrome.

Main Results:

  • Two BD patients had paired mutations in the MVK gene, presenting features of both BD and MKD.
  • One BD patient had a V198M mutation in the CIAS1 gene without CAPS symptoms.
  • A new PSTPIP1 variant (c.741+33_741+34insGT) was identified as a polymorphism, not a mutation, with similar prevalence in patients and controls.

Conclusions:

  • No significant increase in MVK, CIAS1, or PSTPIP1 mutations was found in Behçet's disease patients compared to controls.
  • The study did not establish a strong genetic link between these specific autoinflammatory genes and Behçet's disease.